Moneycontrol
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
117.875 1.24 (1.04%)

NAV as on 21 Aug, 2017

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Jul 31, 17)
Equity Sector Value
(Rs cr)
Assets %
Aurobindo Pharm Pharmaceuticals 97.01 9.73
Strides Shasun Pharmaceuticals 95.30 9.56
Cipla Pharmaceuticals 84.02 8.43
Divis Labs Pharmaceuticals 75.80 7.60
Cadila Health Pharmaceuticals 48.93 4.91
Torrent Pharma Pharmaceuticals 47.45 4.76
Thyrocare Techn Services 43.20 4.33
Natco Pharma Pharmaceuticals 38.91 3.90
Sequent Scienti Pharmaceuticals 36.75 3.69
Alkem Lab Pharmaceuticals 36.64 3.67
Sector Allocation (Jul 31, 17)
  Sector   % 1-Year
High Low

Pharmaceuticals

81.12 0.00 0.00

Services

9.82 0.00 0.00
Asset Allocation (%) (Jul 31, 17)
Class
%

Equity

90.94

Others / Unlisted

0.04

Debt

0.00

Mutual Funds

N.A

Money Market

4.13

Cash / Call

4.89

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

40.23

Top 10

60.58
Sectors
%

Top 3

90.94
Sections
Follow us on
Available On